IMGN
Immunogen, Inc.

10,977
Loading...
Loading...
News
all
press releases
PureTech Founded Entity Seaport Therapeutics Names Lauren White as Chief Financial Officer
PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ('PureTech' or the 'Company'), a clinical-stage biotherapeutics company, noted that its Founded Entity, Seaport Therapeutics, (Seaport) a...
Business Wire·10mo ago
News Placeholder
More News
News Placeholder
Citigroup Inc. Acquires 50,869 Shares of ImmunoGen, Inc. (NASDAQ:IMGN)
Citigroup Inc. increased its holdings in ImmunoGen, Inc. (NASDAQ:IMGN Free Report) by 26.1% during the third quarter, according to its most recent 13F filing with the Securities and Exchange...
Zolmax·2y ago
News Placeholder
Blair William & Co. IL Lowers Holdings in ImmunoGen, Inc. (NASDAQ:IMGN)
Blair William Co. IL reduced its stake in shares of ImmunoGen, Inc. (NASDAQ:IMGN Free Report) by 0.7% during the 3rd quarter, according to its most recent disclosure with the Securities...
Ticker Report·2y ago
News Placeholder
Quantbot Technologies LP Sells 3,962 Shares of ImmunoGen, Inc. (NASDAQ:IMGN)
Quantbot Technologies LP cut its holdings in ImmunoGen, Inc. (NASDAQ:IMGN Free Report) by 35.5% in the 3rd quarter, HoldingsChannel.com reports. The firm owned 7,187 shares of the...
Zolmax·2y ago
News Placeholder
AbbVie completes the acquisition of ImmunoGen
See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
The Fly·2y ago
News Placeholder
AbbVie Completes Acquisition of ImmunoGen
AbbVie Completes Acquisition of ImmunoGen AbbVie Completes Acquisition of ImmunoGen PR Newswire NORTH CHICAGO, Ill., Feb. 12, 2024 Adds flagship antibody-drug conjugate (ADC) ELAHERE (mirvetuximab...
PR Newswire·2y ago
News Placeholder
Barclays Keeps Their Hold Rating on ImmunoGen (IMGN)
In a report released on February 9, Peter Lawson from Barclays maintained a Hold rating on ImmunoGen (IMGN Research Report), with a price target...
TipRanks Financial Blog·2y ago
News Placeholder
ImmunoGen, Inc. (NASDAQ:IMGN) Has Found A Path To Profitability
We feel now is a pretty good time to analyse ImmunoGen, Inc.'s ( NASDAQ:IMGN ) business as it appears the company may...
Simply Wall St·2y ago
News Placeholder
ImmunoGen (IMGN, $29.55) Aroon Indicator entered a Downtrend on February 07, 2024.
For the last three days, A.I.dvisor has detected that IMGN's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong...
Tickeron - Technical Analysis·2y ago
News Placeholder
ImmunoGen (NASDAQ:IMGN) Now Covered by StockNews.com
Research analysts at StockNews.com assumed coverage on shares of ImmunoGen (NASDAQ:IMGN Get Free Report) in a research note issued on Tuesday. The firm set a hold rating on the...
Zolmax·2y ago

Latest IMGN News

View

Advertisement. Remove ads.

Advertisement. Remove ads.